IL9 and polycystic ovary syndrome: Lastly, while MCP-1/CCL2 and IL-9 are proposed as potential biomarkers for PCOS and endometriosis, respectively, supported by pre-clinical and observational data, their specificity in real-world clinical applications remains uncertain.